INVEGA HAFYERA

NDC product · U.S. Food and Drug Administration (openFDA) · United States

  • Product NDC 50458-612
  • Package NDC 50458-612-01
  • Application number NDA207946
  • SPL ID 2e6ef0e1-19d2-7d78-e063-6394a90ae8a6
  • SPL set ID 6cd61892-d2cb-434d-83ed-5c1b2c4e7a0b
  • UNII R8P8USM8FR
  • RxCUI 2570418
  • RxCUI 2570419
  • RxCUI 2570420
  • RxCUI 2570421

What the source publishes

Labeler
Janssen Pharmaceuticals, Inc
Active ingredients
paliperidone palmitate
Form
INJECTION, SUSPENSION, EXTENDED RELEASE
Routes
INTRAMUSCULAR
Administrative status
present-in-source-snapshot
Marketing status
NDA
Product type
HUMAN PRESCRIPTION DRUG
Prescription
Prescription or restricted

Names this record is found by

Complete source data
us:fda:ndc:50458-612_2e6ef0e1-19d2-7d78-e063-6394a90ae8a6
{
  "name": "INVEGA HAFYERA",
  "splId": "2e6ef0e1-19d2-7d78-e063-6394a90ae8a6",
  "labels": [
    {
      "setId": "6cd61892-d2cb-434d-83ed-5c1b2c4e7a0b",
      "labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=6cd61892-d2cb-434d-83ed-5c1b2c4e7a0b",
      "labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=6cd61892-d2cb-434d-83ed-5c1b2c4e7a0b"
    }
  ],
  "routes": [
    "INTRAMUSCULAR"
  ],
  "labeler": "Janssen Pharmaceuticals, Inc",
  "finished": true,
  "packaging": [
    {
      "sample": false,
      "description": "1 SYRINGE in 1 CARTON (50458-612-01)  / 5 mL in 1 SYRINGE",
      "package_ndc": "50458-612-01",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20210830"
    }
  ],
  "productId": "50458-612_2e6ef0e1-19d2-7d78-e063-6394a90ae8a6",
  "useDomain": "unknown",
  "dosageForm": "INJECTION, SUSPENSION, EXTENDED RELEASE",
  "productNdc": "50458-612",
  "deaSchedule": null,
  "genericName": "paliperidone palmitate",
  "productType": "HUMAN PRESCRIPTION DRUG",
  "listingStatus": "present-in-source-snapshot",
  "targetSpecies": [],
  "approvalStatus": "not-established-by-ndc-listing",
  "labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
  "marketingEndDate": null,
  "activeIngredients": [
    {
      "name": "PALIPERIDONE PALMITATE",
      "strength": "1560 mg/5mL"
    }
  ],
  "applicationNumber": "NDA207946",
  "marketingCategory": "NDA",
  "stateRestrictions": {
    "status": "not-collected",
    "observations": []
  },
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "us.fda.ndc"
  },
  "marketingStartDate": "20210830",
  "targetSpeciesStatus": "not-reported",
  "prescriptionCategory": "prescription-or-restricted",
  "harmonizedIdentifiers": {
    "unii": [
      "R8P8USM8FR"
    ],
    "rxcui": [
      "2570418",
      "2570419",
      "2570420",
      "2570421"
    ],
    "spl_set_id": [
      "6cd61892-d2cb-434d-83ed-5c1b2c4e7a0b"
    ],
    "manufacturer_name": [
      "Janssen Pharmaceuticals, Inc"
    ],
    "is_original_packager": [
      true
    ]
  },
  "listingExpirationDate": "20261231"
}

Read this record from your own software

The same record, with every field and its provenance, is one request away. An API key is free and works immediately.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=us" \
  --data-urlencode "sourceId=us.fda.ndc" \
  --data-urlencode "id=us:fda:ndc:50458-612_2e6ef0e1-19d2-7d78-e063-6394a90ae8a6"